[go: up one dir, main page]

AU2020900269A0 - Probiotic formulation and delivery - Google Patents

Probiotic formulation and delivery

Info

Publication number
AU2020900269A0
AU2020900269A0 AU2020900269A AU2020900269A AU2020900269A0 AU 2020900269 A0 AU2020900269 A0 AU 2020900269A0 AU 2020900269 A AU2020900269 A AU 2020900269A AU 2020900269 A AU2020900269 A AU 2020900269A AU 2020900269 A0 AU2020900269 A0 AU 2020900269A0
Authority
AU
Australia
Prior art keywords
delivery
probiotic formulation
probiotic
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020900269A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proagni Pty Ltd
Austrianova Singapore Pte Ltd
Original Assignee
Proagni Pty Ltd
Austrianova Singapore Pte Ltd
Filing date
Publication date
Application filed by Proagni Pty Ltd, Austrianova Singapore Pte Ltd filed Critical Proagni Pty Ltd
Publication of AU2020900269A0 publication Critical patent/AU2020900269A0/en
Assigned to AUSTRIANOVA SINGAPORE PTE LTD, ProAgni Pty Ltd reassignment AUSTRIANOVA SINGAPORE PTE LTD Amend patent request/document other than specification (104) Assignors: ProAgni Pty Ltd
Priority to US17/796,553 priority Critical patent/US20240261347A1/en
Priority to CA3169611A priority patent/CA3169611A1/en
Priority to IL295217A priority patent/IL295217A/en
Priority to EP21747327.1A priority patent/EP4096426A4/en
Priority to AU2021213029A priority patent/AU2021213029B2/en
Priority to BR112022015098A priority patent/BR112022015098A2/en
Priority to PCT/AU2021/050064 priority patent/WO2021151161A1/en
Abandoned legal-status Critical Current

Links

AU2020900269A 2020-01-31 2020-01-31 Probiotic formulation and delivery Abandoned AU2020900269A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US17/796,553 US20240261347A1 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
CA3169611A CA3169611A1 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
IL295217A IL295217A (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
EP21747327.1A EP4096426A4 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
AU2021213029A AU2021213029B2 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
BR112022015098A BR112022015098A2 (en) 2020-01-31 2021-01-29 PROBIOTICS FORMULATION AND DELIVERY
PCT/AU2021/050064 WO2021151161A1 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery

Publications (1)

Publication Number Publication Date
AU2020900269A0 true AU2020900269A0 (en) 2020-02-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP4183391A4 (en) Pharmaceutical composition and use thereof
EP4110066A4 (en) Formulations and uses thereof
EP3937861A4 (en) Stent and stent delivery
ZA202105586B (en) Pharmaceutical delivery compositions and uses thereof
EP4129283A4 (en) Pharmaceutical combination and use thereof
EP4096426A4 (en) Probiotic formulation and delivery
EP4140480A4 (en) Drug combination and use thereof
AU2020900269A0 (en) Probiotic formulation and delivery
EP4100012A4 (en) Drug products for intranasal administration and uses thereof
EP4051017A4 (en) Probiotic compositions and methods
EP4364735A4 (en) Pharmaceutical composition and use thereof
GB202001381D0 (en) Probiotic formulation and delivery
EP4100471A4 (en) Mucoadhersive polymeric drug delivery compositions and methods
EP4342492A4 (en) Pharmaceutical combination and use thereof
EP4349351A4 (en) Lactobacillus plantarum-derived vesicle and use thereof
AU2021902932A0 (en) Probiotic compositions and uses thereof
EP3893914A4 (en) Maleate of scy-635 and uses thereof in medicine
CA3262323A1 (en) Probiotic compositions and therapeutic uses thereof
AU2020903211A0 (en) Probiotic compositions and uses thereof
HK40112722A (en) Sprayable formulation comprising viable and/or stable bacteria
HK40089929A (en) Pharmaceutical formulations and uses thereof
HK40116696A (en) Pharmaceutical composition and use thereof
HK40110967A (en) Pharmaceutical composition and use thereof
HK40111880A (en) Low-dose naltrexol and uses thereof
HK40099664A (en) Pharmaceutical composition and use thereof